Oregon Cancer

News and information for cancer services throughout Oregon.

  • Dose-escalation studies aspire to fill gaps in cancer treatment options

    Dose-escalation studies aspire to fill gaps in cancer treatment options

    Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.

    Read Article
  • FDA approves cellular therapy, offering hope to more people with cancer

    FDA approves cellular therapy, offering hope to more people with cancer

    The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).

    Read Article
  • Providence oncology nurse practitioner receives Values in Action Award

    Providence oncology nurse practitioner receives Values in Action Award

    Jamie Zilverberg, MSN, FNP, AOCNP, receives the prestigious 2024 Values in Action Award, the highest honor given at Providence St. Joseph Health.

    Read Article
  • Celebrating Women in Science

    Celebrating Women in Science

    In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.

    Read Article
  • Register for a free virtual education talk on food and common cancer myths

    Register for a free virtual education talk on food and common cancer myths

    Providence Cancer Institute registered dietitian to present a free virtual education talk on nutrition in March.

    Read Article
  • Studies address need for more treatment options in endometrial cancer and AML

    Studies address need for more treatment options in endometrial cancer and AML

    New study evaluates immunotherapy in combination with other medications in people with endometrial cancer, and a phase I trial for people with AML assesses a non-engineered natural killer cell therapy

    Read Article
  • Documentary film features Providence patients, researchers in pursuit of revolutionary cancer therapy

    Documentary film features Providence patients, researchers in pursuit of revolutionary cancer therapy

    "Within Reach: The Fight to Finish Cancer" follows patient participants and teams of researchers and clinicians at Providence Cancer Institute working to create a living drug for incurable cancers.

    Read Article
  • Promising results of amivantamab studies appear in high-profile journals

    Promising results of amivantamab studies appear in high-profile journals

    New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.

    Read Article
  • A remarkable year of engagement and advancements at Providence Cancer Institute

    A remarkable year of engagement and advancements at Providence Cancer Institute

    Highlights from 2023 events, achievements and advancements at Providence Cancer Institute.

    Read Article
  • Meet Dr. Anderson: At home in Hood River, on a trail, beach or mountaintop

    Meet Dr. Anderson: At home in Hood River, on a trail, beach or mountaintop

    Providence hematology oncologist and outdoors enthusiast Eric C. Anderson, M.D., shares his love of the Pacific Northwest and his philosophy of care for patients.

    Read Article
  • Immunotherapies for GI and lung cancers evaluated in new studies

    Immunotherapies for GI and lung cancers evaluated in new studies

    A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.

    Read Article
  • Genomic testing can improve outcomes for people with advanced cancer, study shows

    Genomic testing can improve outcomes for people with advanced cancer, study shows

    Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

    Read Article
  • Providence researchers contribute to 21 studies at SITC2023

    Providence researchers contribute to 21 studies at SITC2023

    SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.

    Read Article
  • Watch a free virtual talk on lung cancer prevention and treatment

    Watch a free virtual talk on lung cancer prevention and treatment

    Providence Cancer Institute lung cancer expert to present a virtual education talk on lung cancer screening, prevention and latest treatments.

    Read Article
  • New studies address unmet needs in treating triple-negative breast cancer

    New studies address unmet needs in treating triple-negative breast cancer

    Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.

    Read Article
  • Dr. Urba receives award for his contributions to science and community

    Dr. Urba receives award for his contributions to science and community

    Providence Cancer Institute of Oregon, and research director, Earle A. Chiles Research Institute, Walter J. Urba, M.D., Ph.D., receives award for his contributions to science and community.

    Read Article
  • Recognizing the important contributions of oncology APPs

    Recognizing the important contributions of oncology APPs

    Providence Cancer Institute celebrates Advanced Practice Providers Week from September 25 to 29 and recognizes their important contributions more than 25 clinics and programs.

    Read Article
  • New division director and deputy director of Hematology and Medical Oncology share a vision

    New division director and deputy director of Hematology and Medical Oncology share a vision

    Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.

    Read Article
  • New study aims to fill treatment gap for patients with endometrial cancer

    New study aims to fill treatment gap for patients with endometrial cancer

    For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.

    Read Article
  • Two trials evaluate new approaches to treating non-Hodgkin and follicular lymphomas

    Two trials evaluate new approaches to treating non-Hodgkin and follicular lymphomas

    New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.

    Read Article
  • loading
    Loading More...